-
1
-
-
0023772551
-
Oral use of human alpha interferon in cats
-
CUMMINS, J.M., TOMPKINS, M.B., OLSEN, R.G., TOMPKINS, W.A., and LEWIS, M.G. (1988). Oral use of human alpha interferon in cats. J. Biol. Response Mod. 7, 513-523.
-
(1988)
J. Biol. Response Mod.
, vol.7
, pp. 513-523
-
-
Cummins, J.M.1
Tompkins, M.B.2
Olsen, R.G.3
Tompkins, W.A.4
Lewis, M.G.5
-
2
-
-
0025011019
-
Low-dose oral administration of human interferon alpha can control development of Theileria parava infection in cattle
-
YOUNG, A.S., MARITIM, A.C., KARIUKI, D.P., STAGG, D.A, WAFULA, J.M., MUTUGI, J.J., CUMMINS, J.M., RICHARDS, A.B., and BURNS, C. (1990). Low-dose oral administration of human interferon alpha can control development of Theileria parava infection in cattle. Parasitology 101, 201-209.
-
(1990)
Parasitology
, vol.101
, pp. 201-209
-
-
Young, A.S.1
Maritim, A.C.2
Kariuki, D.P.3
Stagg, D.A.4
Wafula, J.M.5
Mutugi, J.J.6
Cummins, J.M.7
Richards, A.B.8
Burns, C.9
-
3
-
-
0027732797
-
Oral therapy with human interferon alpha in calves experimentally injected with infectious bovine rhinotracheitis virus
-
CUMMINS, J.M., HUTCHINSON, D.P., CUMMINS, M.J., GEORGIADES, J.A., and RICHARDS, A.B. (1993). Oral therapy with human interferon alpha in calves experimentally injected with infectious bovine rhinotracheitis virus. Arch. Immunol. Ther. Exp. 41, 193-197.
-
(1993)
Arch. Immunol. Ther. Exp.
, vol.41
, pp. 193-197
-
-
Cummins, J.M.1
Hutchinson, D.P.2
Cummins, M.J.3
Georgiades, J.A.4
Richards, A.B.5
-
4
-
-
0028964995
-
Modification of acute experimental autoimmune encephalomyelitis in the Lewis rat by oral administration of type I interferons
-
BROD, S.A., ACOTT, M., BURNS, D.K., and PHILLIPS, J.T. (1995). Modification of acute experimental autoimmune encephalomyelitis in the Lewis rat by oral administration of type I interferons. J. Interferon Cytokine Res. 15, 115-122.
-
(1995)
J. Interferon Cytokine Res.
, vol.15
, pp. 115-122
-
-
Brod, S.A.1
Acott, M.2
Burns, D.K.3
Phillips, J.T.4
-
5
-
-
0029985565
-
Oral administration of IFN-α is superior to subcutaneous administration of IFN-α in the suppression of chronic relapsing experimental autoimmune encephalomyelitis
-
BROD, S.A., and KHAN, M. (1996). Oral administration of IFN-α is superior to subcutaneous administration of IFN-α in the suppression of chronic relapsing experimental autoimmune encephalomyelitis. J. Autoimmunity 9, 11-20.
-
(1996)
J. Autoimmunity
, vol.9
, pp. 11-20
-
-
Brod, S.A.1
Khan, M.2
-
6
-
-
0028903315
-
Oral administration of human or murine interferon alpha suppresses relapses and modifies adoptive transfer in experimental autoimmune encephalomyelitis
-
BROD, S.A., KAHN, M., KERMAN, R.H., and PAPPOLLA, M. (1995). Oral administration of human or murine interferon alpha suppresses relapses and modifies adoptive transfer in experimental autoimmune encephalomyelitis. J. Neuroimmunol. 58, 61-69.
-
(1995)
J. Neuroimmunol.
, vol.58
, pp. 61-69
-
-
Brod, S.A.1
Kahn, M.2
Kerman, R.H.3
Pappolla, M.4
-
7
-
-
0029789141
-
Suppression of adjuvant arthritis in rats by oral administration of type II collagen in combination with type I interferon
-
YOSHINO, S. (1996). Suppression of adjuvant arthritis in rats by oral administration of type II collagen in combination with type I interferon. J. Pharm. Pharmacol. 48, 702-705.
-
(1996)
J. Pharm. Pharmacol.
, vol.48
, pp. 702-705
-
-
Yoshino, S.1
-
8
-
-
0029557731
-
The preventive effect of oral administration of type I interferon on collagen-induced arthritis in rats
-
YOSHINO, S. (1995). The preventive effect of oral administration of type I interferon on collagen-induced arthritis in rats. Exp. Mol. Pathol. 62, 123-130.
-
(1995)
Exp. Mol. Pathol.
, vol.62
, pp. 123-130
-
-
Yoshino, S.1
-
9
-
-
0023575767
-
Low-dose oral interferon in patient with AIDS
-
HATCHINSON, V., and CUMMINS, J.M. (1987). Low-dose oral interferon in patient with AIDS. Lancet 2, 1530-1531.
-
(1987)
Lancet
, vol.2
, pp. 1530-1531
-
-
Hatchinson, V.1
Cummins, J.M.2
-
10
-
-
0025437391
-
Low dose oral alpha-interferon therapy for patients seropositive for human immunodeficiency virus-type 1 (HIV-1)
-
KOECH, D.K., OBEL, A.O., MINOWADA, J., HUTCHINSON, V.A., and CUMMINS, J.M. (1990). Low dose oral alpha-interferon therapy for patients seropositive for human immunodeficiency virus-type 1 (HIV-1). Mol. Biother. 2, 91-95.
-
(1990)
Mol. Biother.
, vol.2
, pp. 91-95
-
-
Koech, D.K.1
Obel, A.O.2
Minowada, J.3
Hutchinson, V.A.4
Cummins, J.M.5
-
11
-
-
0025453092
-
Efficacy of kemron (low dose oral natural human interferon alpha) in the management of HIV-I infection and acquired immune deficiency syndrome (AIDS)
-
KOECH, D.K., and OBEL, A.O. (1990). Efficacy of kemron (low dose oral natural human interferon alpha) in the management of HIV-I infection and acquired immune deficiency syndrome (AIDS). East Afr. Med. J. 67, SS.64-SS.71.
-
(1990)
East Afr. Med. J.
, vol.67
-
-
Koech, D.K.1
Obel, A.O.2
-
12
-
-
0028411424
-
Three open-label studies of oral interferon alpha in the treatment of HIV disease
-
JORDAN, W.C. (1994). Three open-label studies of oral interferon alpha in the treatment of HIV disease. J. Natl. Med. Assoc. 86, 257-262.
-
(1994)
J. Natl. Med. Assoc.
, vol.86
, pp. 257-262
-
-
Jordan, W.C.1
-
13
-
-
0027748282
-
Treatment of chronic viral hepatitis type B with oral mucosal administration of natural human interferon alpha lozenges
-
CABAN, J., MOSSOR-OSTROWSKA, J., ZYRKOWSKA-BIEDA, T., ZEJC, M., JANAS-SKULINA, U., CIESLA, A., CUMMINS, J.M., and GEORGIADES, J.A. (1993). Treatment of chronic viral hepatitis type B with oral mucosal administration of natural human interferon alpha lozenges. Arch. Immunol. Ther. Exp. 41, 229-235.
-
(1993)
Arch. Immunol. Ther. Exp.
, vol.41
, pp. 229-235
-
-
Caban, J.1
Mossor-Ostrowska, J.2
Zyrkowska-Bieda, T.3
Zejc, M.4
Janas-Skulina, U.5
Ciesla, A.6
Cummins, J.M.7
Georgiades, J.A.8
-
14
-
-
0029758682
-
Natural human interferon a given orally has different effects on patients with distinct forms of chronic viral hepatitis B
-
GEORGIADES, J.A., CABAN, J., ZYRKOWSKA-BIEDA, T., ZEJC, M., JONAS-SKULINA, U., and CIESLA, A. (1996). Natural human interferon a given orally has different effects on patients with distinct forms of chronic viral hepatitis B. Arch. Immunol. Ther. Exp. 44, 187-194.
-
(1996)
Arch. Immunol. Ther. Exp.
, vol.44
, pp. 187-194
-
-
Georgiades, J.A.1
Caban, J.2
Zyrkowska-Bieda, T.3
Zejc, M.4
Jonas-Skulina, U.5
Ciesla, A.6
-
15
-
-
0027733897
-
Treatment of six patients with chronic active HCV hepatitis with low-dose natural interferon alpha administered orally
-
ZIELINSKA, W., PASZKIEWICZ, J., KORCZAK, A., WLASIUK, M., ZOLTOWSKA, A., SZUTOWICZ, A., CUMMINS, J.M., and GEORGIADES, J.A. (1993). Treatment of six patients with chronic active HCV hepatitis with low-dose natural interferon alpha administered orally. Arch. Immunol. Ther. Exp. 41, 253-257.
-
(1993)
Arch. Immunol. Ther. Exp.
, vol.41
, pp. 253-257
-
-
Zielinska, W.1
Paszkiewicz, J.2
Korczak, A.3
Wlasiuk, M.4
Zoltowska, A.5
Szutowicz, A.6
Cummins, J.M.7
Georgiades, J.A.8
-
16
-
-
85038544338
-
Effect of oral IFN-α on saliva secretion in Sjögren's syndrome
-
SHIOZAWA, K., TANAKA, Y., HISHIHARA, Y., HIRATA, M., IMURA, S., and SIOZAWA, S. (1994). Effect of oral IFN-α on saliva secretion in Sjögren's syndrome. Ryumachi 34, F586.
-
(1994)
Ryumachi
, vol.34
-
-
Shiozawa, K.1
Tanaka, Y.2
Hishihara, Y.3
Hirata, M.4
Imura, S.5
Siozawa, S.6
-
17
-
-
0017724079
-
Distribution of cells mediating delayed-type hypersensitivity responses of mice to sheep red blood cells
-
KWAST, T.H., and BENNER, R. (1997). Distribution of cells mediating delayed-type hypersensitivity responses of mice to sheep red blood cells. Ann. Immunol. 128C, 833-840.
-
(1997)
Ann. Immunol.
, vol.128 C
, pp. 833-840
-
-
Kwast, T.H.1
Benner, R.2
-
18
-
-
0022005194
-
Interferon enhances the susceptibility of virus-infected fibroblasts to cytotoxic T cells
-
BUKOWSKI, J.F., and WELSH, R.D. (1985). Interferon enhances the susceptibility of virus-infected fibroblasts to cytotoxic T cells. J. Exp. Med. 161, 257-262.
-
(1985)
J. Exp. Med.
, vol.161
, pp. 257-262
-
-
Bukowski, J.F.1
Welsh, R.D.2
-
19
-
-
0014276973
-
Further improvements in the plaque technique for detecting single antibody-forming cells
-
CUNNINGHAM, A.J., and SZENBERG, A. (1968). Further improvements in the plaque technique for detecting single antibody-forming cells. Imunology 14, 599-600.
-
(1968)
Imunology
, vol.14
, pp. 599-600
-
-
Cunningham, A.J.1
Szenberg, A.2
-
20
-
-
0013979057
-
Evaluation of antiviral compounds by suppression of tail lesions in vaccinia-infected mice
-
BOYLE, J.J., HAFF, R.F., and STEWART, R.C. (1966). Evaluation of antiviral compounds by suppression of tail lesions in vaccinia-infected mice. Antimicrob. Agents Chemother. 1966, 536-539.
-
(1966)
Antimicrob. Agents Chemother.
, vol.1966
, pp. 536-539
-
-
Boyle, J.J.1
Haff, R.F.2
Stewart, R.C.3
-
21
-
-
0026746424
-
Orally administered interferons exert their white blood cell suppressive effects via a novel mechanism
-
FLEISCHMANN, W.R., Jr., KOREN, S., and FLEISCHMANN, C.M. (1992). Orally administered interferons exert their white blood cell suppressive effects via a novel mechanism. Proc. Soc. Exp. Biol. Med. 201, 200-207.
-
(1992)
Proc. Soc. Exp. Biol. Med.
, vol.201
, pp. 200-207
-
-
Fleischmann Jr., W.R.1
Koren, S.2
Fleischmann, C.M.3
-
22
-
-
0023747270
-
Oral administration of human recombinant interferon-α2 in rats
-
PAULESU, L., CORRADESCHI, F., NICOLETTI, C., and BOCCI, V. (1988). Oral administration of human recombinant interferon-α2 in rats. Int. J. Pharmaceutics 46, 199-202.
-
(1988)
Int. J. Pharmaceutics
, vol.46
, pp. 199-202
-
-
Paulesu, L.1
Corradeschi, F.2
Nicoletti, C.3
Bocci, V.4
-
23
-
-
0022640843
-
Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins
-
MOSMANN, T.R., CHERWINSKI, H., BOND, M.W., GIEDLIN, M.A., and COFFMAN, R.L. (1986). Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. J. Immunol. 136, 2348-2357.
-
(1986)
J. Immunol.
, vol.136
, pp. 2348-2357
-
-
Mosmann, T.R.1
Cherwinski, H.2
Bond, M.W.3
Giedlin, M.A.4
Coffman, R.L.5
-
24
-
-
0030803798
-
Low-dose oral type I interferons reduce early virus replication of murine cytomegalovirus in vivo
-
BEILHARZ, M.W., McDONALD, W., WATSON, M.W., HENG, J., McGEACHIE, J., and LAWSON, C.M. (1997). Low-dose oral type I interferons reduce early virus replication of murine cytomegalovirus in vivo. J. Interferon Cytokine Res. 17, 625-630.
-
(1997)
J. Interferon Cytokine Res.
, vol.17
, pp. 625-630
-
-
Beilharz, M.W.1
McDonald, W.2
Watson, M.W.3
Heng, J.4
McGeachie, J.5
Lawson, C.M.6
-
25
-
-
0027380798
-
Orally administered interferons suppress bone marrow function
-
KOREN, S., and FLEISCHMANN, W.R., Jr. (1993). Orally administered interferons suppress bone marrow function. Proc. Soc. Exp. Biol. Med. 204, 155-164.
-
(1993)
Proc. Soc. Exp. Biol. Med.
, vol.204
, pp. 155-164
-
-
Koren, S.1
Fleischmann Jr., W.R.2
|